Champions Oncology, Inc.
CSBR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000771856
No open-market purchases or sales by Champions Oncology, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $36.3M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Champions Oncology, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- 0 vs. Q2 2022
- Shares held
- 6.24M
- +16.8K (+0.3%) vs. Q2 2022
- Total value
- $46.8M
- −$3.02M (−6.1%) vs. Q2 2022
- New holders
- 3
- 7 more added
- Sold out
- 3
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CSBR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $36.3M |
| Q1 2026 | 25 | $33.0M |
| Q4 2025 | 27 | $39.7M |
| Q3 2025 | 27 | $36.7M |
| Q2 2025 | 30 | $42.5M |
| Q1 2025 | 34 | $51.4M |
| Q4 2024 | 25 | $49.0M |
| Q3 2024 | 22 | $28.2M |
| Q2 2024 | 23 | $29.9M |
| Q1 2024 | 25 | $27.6M |
| Q4 2023 | 23 | $31.5M |
| Q3 2023 | 29 | $35.6M |
| Q2 2023 | 28 | $37.0M |
| Q1 2023 | 30 | $23.6M |
| Q4 2022 | 29 | $27.1M |
| Q3 2022 | 32 | $46.8M |
| Q2 2022 | 32 | $49.8M |
| Q1 2022 | 30 | $50.4M |
| Q4 2021 | 31 | $51.7M |
| Q3 2021 | 35 | $64.1M |
| Q2 2021 | 38 | $68.5M |
| Q1 2021 | 45 | $81.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Champions Oncology, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Battery Management Corp. | 2,421,673 | $18.2M | 3.11% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,713,720 | $12.9M | 0.64% | 00.0% | Unchanged |
| Millrace Asset Group, Inc. | 346,976 | $2.60M | 3.29% | −7,065−2.0% | Reduced |
| Tocqueville Asset Management L.P. | 341,666 | $2.56M | 0.05% | +55,055+19.2% | Added |
| Vanguard Group Inc | 335,615 | $2.52M | 0.00% | −10,228−3.0% | Reduced |
| Renaissance Technologies LLC | 142,949 | $1.07M | 0.00% | −21,397−13.0% | Reduced |
| BlackRock Inc. | 122,136 | $916.0K | 0.00% | −1,223−1.0% | Reduced |
| Dimensional Fund Advisors LP | 121,805 | $914.0K | 0.00% | +8,462+7.5% | Added |
| Essex Investment Management Co LLC | 107,711 | $808.0K | 0.13% | −7,364−6.4% | Reduced |
| Ameriprise Financial Inc | 81,693 | $613.0K | 0.00% | −2,484−3.0% | Reduced |
| ACT Capital Management, LLC | 62,500 | $469.0K | 0.65% | 00.0% | Unchanged |
| Millennium Management LLC | 54,422 | $408.0K | 0.00% | +1,874+3.6% | Added |
| Overbrook Management Corp | 53,888 | $404.0K | 0.11% | −10,000−15.7% | Reduced |
| Geode Capital Management, LLC | 47,638 | $357.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,313 | $280.0K | 0.00% | +20,716+124.8% | Added |
| Aristides Capital LLC | 36,750 | $276.0K | 0.24% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 31,476 | $234.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 30,775 | $231.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,067 | $210.0K | 0.00% | +762+2.8% | Added |
| State Street Corp | 26,553 | $199.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 26,467 | $199.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna Fundamental Investments, LLC | 23,100 | $173.0K | 0.00% | +23,100 | New |
| Ergoteles LLC | 13,937 | $105.0K | 0.00% | +13,937 | New |
| Ingalls & Snyder LLC | 11,056 | $83.0K | 0.00% | 00.0% | Unchanged |
| Globeflex Capital L P | 8,549 | $64.0K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 7,800 | $59.0K | 0.00% | +2,400+44.4% | Added |
| Barclays PLC | 1,342 | $10.0K | 0.00% | +1,342 | New |
| Royal Bank of Canada | 178 | $2.00K | 0.00% | +78+78.0% | Added |
| JPMorgan Chase & Co | 11 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 41 | $0 | 0.00% | −3−6.8% | Reduced |
| Simplex Trading, LLC | 94 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 18 | $0 | 0.00% | −15−45.5% | Reduced |
| ClariVest Asset Management LLC | 0 | $0 | 0.00% | −48,200−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −937−100.0% | Sold out |